Nisa Investment Advisors LLC Acquires 6,794 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Nisa Investment Advisors LLC increased its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 3,652.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,980 shares of the company’s stock after acquiring an additional 6,794 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Definitive Healthcare were worth $29,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Point72 DIFC Ltd grew its stake in shares of Definitive Healthcare by 759.9% in the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after acquiring an additional 8,215 shares during the last quarter. Intech Investment Management LLC purchased a new stake in Definitive Healthcare during the 3rd quarter valued at about $55,000. Bleakley Financial Group LLC bought a new stake in Definitive Healthcare during the 3rd quarter valued at about $74,000. Glenmede Trust Co. NA raised its holdings in Definitive Healthcare by 41.1% in the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after buying an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Definitive Healthcare in the third quarter worth approximately $84,000. 98.67% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

DH has been the subject of several analyst reports. Barclays reissued an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a research report on Monday, January 13th. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Finally, Stephens began coverage on Definitive Healthcare in a report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, Definitive Healthcare currently has an average rating of “Hold” and an average target price of $5.72.

Insider Transactions at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now owns 433,830 shares of the company’s stock, valued at $2,039,001. The trade was a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 14.84% of the stock is currently owned by company insiders.

Definitive Healthcare Trading Down 1.2 %

Definitive Healthcare stock opened at $4.86 on Friday. The business has a 50-day simple moving average of $4.42 and a two-hundred day simple moving average of $4.45. Definitive Healthcare Corp. has a 52-week low of $3.19 and a 52-week high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The company has a market cap of $561.44 million, a P/E ratio of -1.57, a P/E/G ratio of 3.70 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last announced its earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.03). The business had revenue of $62.70 million for the quarter, compared to analysts’ expectations of $61.66 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. During the same period in the prior year, the company posted $0.01 earnings per share. Analysts predict that Definitive Healthcare Corp. will post 0.15 EPS for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.